Anne Marieke EZENDAM

Independent Board Member

Advisor, Global Gene Corp (2019-2021)

§Shaping the pharmaceutical business model based on licensing genomics data for drug development, initiate pharma contacts, position for funding

Director, Optimum Strategic Communications
(2018-2019)

 

Portfolio Manager and Healthcare Analyst Amundi (2014-2018)

§Responsible for setting up the team’s research platform

Senior Healthcare Analyst, ING IM (2011-2013)

Various roles, Healthcare Investing (1997-2011)

Manager, 3M & Roche (1994-1997)

 

 

eureKING

128 rue de la Boétie, 75008 Paris, France

info@eureKING.com

Press Contacts

 

Nicolas Merigeau

+33 (0)1 44 71 94 98 

nmerigeau@newcap.fr 

Arthur Rouillé

+33 (0)1 44 71 00 15

arouille@newcap.fr